Literature DB >> 21605815

Pathogenesis of mucous membrane pemphigoid.

A Shadi Kourosh1, Kim B Yancey.   

Abstract

Mucous membrane pemphigoid (MMP) is the clinical phenotype of a group of autoimmune blistering diseases characterized by autoantibodies directed against different structural proteins in epidermal basement membranes. The clinical course and prognosis of MMP are affected by the specific autoantigen targeted, the titer and bioactivity profile of corresponding autoantibodies, and the specific mucosal sites of disease activity. Irreversible scarring and loss of function must be prevented by early diagnosis and appropriate interventions.
Copyright © 2011 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21605815     DOI: 10.1016/j.det.2011.03.011

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  7 in total

Review 1.  Ocular mucous membrane pemphigoid: a review.

Authors:  Samanta Taurone; Marialuisa Spoletini; Massimo Ralli; Pietro Gobbi; Marco Artico; Laszlò Imre; Cecília Czakò; Illés Kovàcs; Antonio Greco; Alessandra Micera
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

Review 2.  The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.

Authors:  J K Dart
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

3.  Aldehyde dehydrogenase inhibition blocks mucosal fibrosis in human and mouse ocular scarring.

Authors:  Sarah D Ahadome; David J Abraham; Suryanarayana Rayapureddi; Valerie P Saw; Daniel R Saban; Virginia L Calder; Jill T Norman; Markella Ponticos; Julie T Daniels; John K Dart
Journal:  JCI Insight       Date:  2016-08-04

4.  Unilateral oral mucous membrane pemphigoid: refractory atypical presentation successfully treated with intravenous immunoglobulins.

Authors:  André Laureano; Jorge Cardoso
Journal:  Case Rep Dermatol Med       Date:  2015-02-15

5.  [A particular type of cicatricial Pemphigoid with unique IgA deposit].

Authors:  Amina Aounallah; Mariem Jrad; Mehdi Ksiaa; Sana Mokni; Wafa Saidi; Lobna Boussofara; Badreddine Sriha; Mohamed Denguezli; Najet Ghariani; Colandane Belajouza; Rafia Nouira
Journal:  Pan Afr Med J       Date:  2017-03-13

6.  The Second Study of Clinical and Immunological Findings in Anti-laminin 332-Type Mucous Membrane Pemphigoid Examined at Kurume University-Diagnosis Criteria Suggested by Summary of 133 Cases.

Authors:  Hua Qian; Yohei Natsuaki; Hiroshi Koga; Tamihiro Kawakami; Chiharu Tateishi; Daisuke Tsuruta; Norito Ishii; Xiaoguang Li; Takashi Hashimoto
Journal:  Front Immunol       Date:  2021-11-26       Impact factor: 7.561

7.  Successful treatment of mucous membrane pemphigoid with bortezomib.

Authors:  Lina Saeed; Timothy H Schmidt; Lianne S Gensler; Andrew J Gross; Lindy P Fox; Tiffany C Scharschmidt; Karin Gaensler; Haley Naik; Michael A Rosenblum; Kanade Shinkai
Journal:  JAAD Case Rep       Date:  2017-12-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.